Skip to main content

Table 4 Summary of the outcome of studies conducted with cord blood TNC

From: Cell therapies for autism spectrum disorder: a systematic review of clinical applications

 

Chez et al. [15]

Dawson et al. [20]

Dawson et al. [21]

Simhal et al. [81]

CGI-I

No change

Improved significantly

Improveda

No change

CGI-S

No change

Improved significantly

No change

-

EOWPVT

No change

Improved significantly

No change

No change

ROWPVT

No change

Improved significantly

-

-

VABS

No change

Improved significantly

Improved

No change

PDDBI

-

-

No change

No change

Daily skills, learning capacity

No change

Improved significantly

-

No change

Social interaction

No change

Improved significantly

No change

No change

Adaptive behavior

No change

Improved significantly

-

No change

Verbal cognitive ability

No change

Improved significantly

-

No change

Brain network reconfiguration

-

-

Significant changeb

Significant changeb

Major adverse events

None

None

None

-

  1. aCGI rating improvement was observed when only participants with NVIQ≥70 were compared with the placebo group
  2. bSignificant change was observed when statistical analyses were performed by grouping patients according to their nonverbal IQ